Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Arora
S Samdhani
A S Bapna

Showing results (51-60 of 105) with videos related to

Pageof 11
Sort By:
The Journal of the Association of Physicians of India|September 1, 1993
Toxicity of exposed aluminium phosphideS N Chugh, V Arora, S Kaur, et al.
Ophthalmology|March 1, 1992
Influence of coralline hydroxyapatite used as an ocular implant on the dose distribution of external beam photon radiation therapyV Arora, K Weeks, E C Halperin, et al.
International Journal of Oral and Maxillofacial Surgery|January 22, 2016
Implant-retained auricular prostheses: a clinical challengeV Arora, N K Sahoo, A Gopi, et al.
Lupus|June 11, 2011
Relationship of leukocyte CR1 transcript and protein with the pathophysiology and prognosis of systemic lupus erythematosus: a follow-up studyV Arora, R Grover, A Kumar, et al.
Indian Journal of Pathology & Microbiology|October 1, 1988
Fine needle aspiration cytology of epididymal nodulesV Kumar, A Bhatia, K Misra, et al.
Endocrinology|March 1, 1996
Biphasic action of cyclic adenosine 3',5'- monophosphate in gonadotropin-releasing hormone (GnRH) analog-stimulated hormone release from GH3 cells stably transfected with GnRH receptor complementary deoxyribonucleic acidD Stanislaus, V Arora, W M Awara, et al.
Anaesthesia|March 1, 1973
Initial clinical experience with AH 8165D, a new rapidly acting nondepolarizing muscle relaxantM V Arora, R S Clarke, J W Dundee, et al.
Clinical Therapeutics|May 13, 1999
Improved postprandial blood glucose control and reduced nocturnal hypoglycemia during treatment with two novel insulin lispro-protamine formulations, insulin lispro mix25 and insulin lispro mix50. Mix50 Study GroupP Roach, M Trautmann, V Arora, et al.
Journal of Medicinal Chemistry|July 1, 1970
Potential antidiabetics. V. 3,5-dimethyl-4-arylazo-N-1-carbamoyl-, 3-methyl-4-arylazo-5-phenyl-N-1-carbamoyl-, and 3,5-dimethyl-4-arylazo-N-1-hippurylpyrazolesW U Malik, H G Garg, P P Singh, et al.
Diabetes, Obesity & Metabolism|August 28, 2003
Humalog Mix50 before carbohydrate-rich meals in type 2 diabetes mellitusP Roach, V Arora, B N Campaigne, et al.
Pageof 11

Showing results (51-60 of 105) with videos related to

Sort By:
Pageof 11
The Journal of the Association of Physicians of India|September 1, 1993
Toxicity of exposed aluminium phosphideS N Chugh, V Arora, S Kaur, et al.
Ophthalmology|March 1, 1992
Influence of coralline hydroxyapatite used as an ocular implant on the dose distribution of external beam photon radiation therapyV Arora, K Weeks, E C Halperin, et al.
International Journal of Oral and Maxillofacial Surgery|January 22, 2016
Implant-retained auricular prostheses: a clinical challengeV Arora, N K Sahoo, A Gopi, et al.
Lupus|June 11, 2011
Relationship of leukocyte CR1 transcript and protein with the pathophysiology and prognosis of systemic lupus erythematosus: a follow-up studyV Arora, R Grover, A Kumar, et al.
Indian Journal of Pathology & Microbiology|October 1, 1988
Fine needle aspiration cytology of epididymal nodulesV Kumar, A Bhatia, K Misra, et al.
Endocrinology|March 1, 1996
Biphasic action of cyclic adenosine 3',5'- monophosphate in gonadotropin-releasing hormone (GnRH) analog-stimulated hormone release from GH3 cells stably transfected with GnRH receptor complementary deoxyribonucleic acidD Stanislaus, V Arora, W M Awara, et al.
Anaesthesia|March 1, 1973
Initial clinical experience with AH 8165D, a new rapidly acting nondepolarizing muscle relaxantM V Arora, R S Clarke, J W Dundee, et al.
Clinical Therapeutics|May 13, 1999
Improved postprandial blood glucose control and reduced nocturnal hypoglycemia during treatment with two novel insulin lispro-protamine formulations, insulin lispro mix25 and insulin lispro mix50. Mix50 Study GroupP Roach, M Trautmann, V Arora, et al.
Journal of Medicinal Chemistry|July 1, 1970
Potential antidiabetics. V. 3,5-dimethyl-4-arylazo-N-1-carbamoyl-, 3-methyl-4-arylazo-5-phenyl-N-1-carbamoyl-, and 3,5-dimethyl-4-arylazo-N-1-hippurylpyrazolesW U Malik, H G Garg, P P Singh, et al.
Diabetes, Obesity & Metabolism|August 28, 2003
Humalog Mix50 before carbohydrate-rich meals in type 2 diabetes mellitusP Roach, V Arora, B N Campaigne, et al.
Pageof 11